Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$395K Hold
3,073
0.21% 105
2026
Q1
$370K Sell
3,073
-4,999
-62% -$577K 0.28% 82
2025
Q4
$307K Buy
8,072
+5,529
+217% +$519K 0.24% 91
2025
Q3
$213K Buy
+2,543
New +$209K 0.2% 119
2025
Q2
Sell
-2,530
Closed -$227K 116
2025
Q1
$227K Hold
2,530
0.27% 93
2024
Q4
$252K Buy
+2,530
New +$261K 0.35% 79

Other funds holding MRK

BXM Wealth's MRK Position: Q2 2026 in Review

BXM Wealth held its Merck (MRK) position steady in Q2 2026 at 3,073 shares worth $395K. The position accounts for 0.21% of the portfolio, ranked #105.

BXM Wealth first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 1,346 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • BXM Wealth held 3,073 shares of Merck worth $395K as of Q2 2026.
  • BXM Wealth left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.21% of BXM Wealth's portfolio in Q2 2026, its #105 holding.
  • BXM Wealth first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 1,346 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on BXM Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.